🚀 VC round data is live in beta, check it out!
Biosenic Valuation Multiples
Discover revenue and EBITDA valuation multiples for Biosenic and similar public comparables like HCW Biologics, Nextgen Biomed, China SXT Pharmaceuticals, Aptahem and more.
Biosenic Overview
About Biosenic
Biosenic is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.
Founded
2006
HQ
Employees
11
Website
Sectors
Financials (FY)
EV
$33M
Biosenic Financials
Biosenic reported last fiscal year revenue of — and negative EBITDA of ($6M).
In the same fiscal year, Biosenic generated ($6M) in EBITDA losses and had net loss of ($6M).
Biosenic P&L
In the most recent fiscal year, Biosenic reported revenue of — and EBITDA of ($6M).
Biosenic expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | ($6M) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($6M) | XXX | XXX | XXX |
| Net Debt | — | — | $32M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Biosenic Stock Performance
Biosenic has current market cap of $2M, and enterprise value of $33M.
Market Cap Evolution
Biosenic's stock price is $0.00.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $33M | $2M | 0.0% | XXX | XXX | XXX | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBiosenic Valuation Multiples
Biosenic trades at (6.0x) EV/EBITDA.
Biosenic Financial Valuation Multiples
As of March 30, 2026, Biosenic has market cap of $2M and EV of $33M.
Equity research analysts estimate Biosenic's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Biosenic has a P/E ratio of (0.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2M | XXX | $2M | XXX | XXX | XXX |
| EV (current) | $33M | XXX | $33M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (6.0x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (5.6x) | XXX | XXX | XXX |
| P/E | — | XXX | (0.3x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (13.0x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Biosenic Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Biosenic Margins & Growth Rates
Biosenic's revenue in the last fiscal year grew by —.
Biosenic's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.5M for the same period.
Biosenic Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | — | XXX | (82%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Biosenic Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| HCW Biologics | XXX | XXX | XXX | XXX | XXX | XXX |
| Nextgen Biomed | XXX | XXX | XXX | XXX | XXX | XXX |
| China SXT Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| Aptahem | XXX | XXX | XXX | XXX | XXX | XXX |
| Reboost Blockchain | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Biosenic M&A Activity
Biosenic acquired XXX companies to date.
Last acquisition by Biosenic was on XXXXXXXX, XXXXX. Biosenic acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Biosenic
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBiosenic Investment Activity
Biosenic invested in XXX companies to date.
Biosenic made its latest investment on XXXXXXXX, XXXXX. Biosenic invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Biosenic
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Biosenic
| When was Biosenic founded? | Biosenic was founded in 2006. |
| Where is Biosenic headquartered? | Biosenic is headquartered in Belgium. |
| How many employees does Biosenic have? | As of today, Biosenic has over 11 employees. |
| Is Biosenic publicly listed? | Yes, Biosenic is a public company listed on Euronext Brussels. |
| What is the stock symbol of Biosenic? | Biosenic trades under BIOS ticker. |
| When did Biosenic go public? | Biosenic went public in 2015. |
| Who are competitors of Biosenic? | Biosenic main competitors are HCW Biologics, Nextgen Biomed, China SXT Pharmaceuticals, Aptahem. |
| What is the current market cap of Biosenic? | Biosenic's current market cap is $2M. |
| Is Biosenic profitable? | No, Biosenic is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.